Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Kaindl

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Leukemia|November 19, 2013
Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemiaU Kaindl, M Morak, C Portsmouth, et al.
Oncogene|March 2, 2010
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1G Krapf, U Kaindl, A Kilbey, et al.
Leukemia|November 19, 2011
Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenograftsG Fuka, H-P Kantner, R Grausenburger, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Leukemia|November 19, 2013
Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemiaU Kaindl, M Morak, C Portsmouth, et al.
Oncogene|March 2, 2010
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1G Krapf, U Kaindl, A Kilbey, et al.
Leukemia|November 19, 2011
Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenograftsG Fuka, H-P Kantner, R Grausenburger, et al.
Pageof 1